相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii
Marie Kempf et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Efflux-Mediated Antibiotic Resistance in Acinetobacter spp.
Sebastien Coyne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Acinetobacter baumannii resistant to everything: what should we do?
J. Vila et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Confronting multidrug-resistant Acinetobacter baumannii: a review
Ioannis K. Neonakis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Multiresistant Acinetobacter baumannii infections: epidemiology and management
Jose Garnacho-Montero et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2010)
Treatment of Acinetobacter infections
Argyris Michalopoulos et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates
Pattarachai Kiratisin et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
Nicola C. Gordon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Nosocomial imipenem-resistant Acinetobacter baumannii infections: Epidemiology and risk factors
Murat Dizbay et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2010)
Rational dosing of antimicrobial agents: Pharmacokinetic and pharmacodynamic strategies
Robert C. Owens et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
Acinetobacter: an old friend, but a new enemy
K. J. Towner
JOURNAL OF HOSPITAL INFECTION (2009)
Acinetobacter baumannii:: Epidemiology, antimicrobial resistance, and treatment options
Lisa L. Maragakis et al.
CLINICAL INFECTIOUS DISEASES (2008)
Treatment options for multidrug-resistant Acinetobacter species
Jacob Gilad et al.
DRUGS (2008)
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
M. S. Oliveira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia:: Four case reports and an in vitro combination synergy study
Nan-Yao Lee et al.
PHARMACOTHERAPY (2007)
Multidrug-resistant Acinetobacter baumannii bacteraemia:: clinical features, antimicrobial therapy and outcome
L. -C. Kuo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis
PJ Petersen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii
CRV Kiffer et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain
WC Ko et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
In vitro activities of β-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria
FD Wang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
In vitro investigation of the susceptibility of Acintetobacter baumannii strains isolated from clinical specimens to ampicillin/sulbactam alone and in combination with amikacin
E Savov et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
How predictive is PK/PD for antibacterial agents?
N Frimodt-Moller
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
分享论文
